January 2, 2007Catheterization and Cardiovascular Interventions
Treatment of recurrent pulmonary vein stenoses with endovascular stenting and adjuvant oral sirolimus
Why the study?
Does endovascular stenting and adjuvant oral sirolimus prevent restenosis in patients with recurrent pulmonary vein stenosis?
Population
2 patients with recurrent pulmonary vein stenosis secondary to radiofrequency catheter ablation for atrial…
Design
Case_series
Follow-up
1 year
Authors
Discussion
Loading...
Member takes
Implication
Stenting with adjuvant sirolimus may prevent restenosis in recurrent pulmonary vein stenosis; hypothesis-generating case report requiring prospective trials.
Structured PICO
Does endovascular stenting and adjuvant oral sirolimus prevent restenosis in patients with recurrent pulmonary vein stenosis?
P
Population
2 patients with recurrent pulmonary vein stenosis (one following percutaneous balloon angioplasty, one following surgical bovine pericardial patch angioplasty) secondary to radiofrequency catheter ablation for atrial fibrillation
I
Intervention
Endovascular stenting and adjuvant oral sirolimus
O
Outcome
Symptoms and evidence of restenosis at 1 year follow-upsurrogate
Endovascular stenting combined with adjuvant oral sirolimus may be an effective treatment for recurrent pulmonary vein stenosis following atrial fibrillation ablation.
Cite This Study
Bromberg‐Marin et al. (2007) studied this question.